XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]      
Common stock issued 39,687,589   39,687,589
Common stock, shares outstanding 39,687,589    
Common stock par value $ 0.01   $ 0.01
Number of options granted during period 95,770    
Fair value of options granted during period $ 38,000    
Number of options exercised    
Intrinsic value of options outstanding $ 94,000   $ 291,000
Intrinsic value of options exercisable 98,000    
Compensation cost, non-vested awards not yet recognized 65,000    
Selling, General and Administrative Expenses [Member]      
Subsidiary, Sale of Stock [Line Items]      
Stock based compensation expense $ 31,000 $ 15,000  
Non Employee Stock Option [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options exercised 0    
Employees [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options granted during period 30,000    
Company's CEO [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options granted during period 35,000    
Company's Vice President [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options granted during period 30,770    
Non-employee [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options granted during period 0    
Amended and Restated 2006 Stock Incentive Plan [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of options available for grant 1,484,850